CBD acts on both CB1 and CB2 receptors with lower affinity for Δ9-THC, producing less adverse effects (e.g., tachycardia, sedation, hunger) but significantly decreasing fear-memory consolidation and anxiety symptoms of PTSD, possibly due to its action on limbic and paralimbic areas [54,55]. The gene discussed is CNR1; the disease is Anxiety.